MRBVX
Price
$15.81
Change
-$0.09 (-0.57%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

MRBVX vs RMFCX

Header iconMRBVX vs RMFCX Comparison
Open Charts MRBVX vs RMFCXBanner chart's image
BlackRock Large Cap Focus Value R
Price$15.81
Change-$0.09 (-0.57%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
MRBVX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MRBVX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRBVX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. MRBVX (1.81B). MRBVX pays higher dividends than RMFCX: MRBVX (2.08) vs RMFCX (1.69). MRBVX was incepted earlier than RMFCX: MRBVX (22 years) vs RMFCX (23 years). MRBVX is a more actively managed with annual turnover of: 80.00 vs. RMFCX (25.00). MRBVX has a lower initial minimum investment than RMFCX: MRBVX (100) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. MRBVX (4.82). RMFCX return over 5 years is better than : 40.39 vs. MRBVX (-8.75).
MRBVXRMFCXMRBVX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years23 years-
Gain YTD3.01111.42326%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.81B104B2%
Annual Yield % from dividends2.081.69123%
Returns for 1 year4.8212.6338%
Returns for 3 years1.9314.1614%
Returns for 5 years-8.7540.39-22%
Returns for 10 years-28.8161.84-47%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc